Company Filing History:
3 out of 634 
2 out of 2 
1 out of 30,066 
Years Active: 2016-2024
Title: Kijoon Lee: Innovator in Revascularization Assessment and Deep Tissue Flowmetry
Introduction
Kijoon Lee is a prominent inventor based in Singapore, known for his significant contributions to the fields of medical technology and blood flow measurement. With a total of 6 patents to his name, Lee has developed innovative systems and methods that enhance the assessment of revascularization and blood flow.
Latest Patents
Among his latest patents, Lee has introduced groundbreaking systems and methods for revascularization assessment. These methods involve measuring blood perfusion over time to obtain time series data, which is then mathematically transformed into a power spectrum. By calculating parameters within specific frequency ranges, these parameters can serve as discriminators between different populations. Another notable patent is focused on deep tissue flowmetry using diffuse speckle contrast analysis. This method calculates blood flow rates by analyzing the spatial and time domains of light diffusion in tissue samples. The use of multi-pixel image sensors allows for the detection of speckle distributions caused by the movement of red blood cells, while time-series fluctuations in light intensity provide further insights into blood flow dynamics.
Career Highlights
Kijoon Lee has had a distinguished career, working with esteemed institutions such as Nanyang Technological University and Pedra Technology Pte Ltd. His work has significantly advanced the understanding of blood flow measurement techniques, making him a key figure in the medical technology sector.
Collaborations
Throughout his career, Lee has collaborated with talented individuals, including Jing Dong and Renzhe Bi. These partnerships have fostered innovation and contributed to the development of his patented technologies.
Conclusion
Kijoon Lee's innovative work in revascularization assessment and deep tissue flowmetry showcases his dedication to advancing medical technology. His contributions have the potential to improve patient outcomes and enhance the understanding of blood flow dynamics.